Tumour-derived microvesicles modulate biological activity of human monocytes

Immunology Letters

Volumn 113, Issue 2, 2007, Pages 76-82

  Baj Krzyworzeka, Monika ^a   Szatanek, Rafał ^a   Weglarczyk, Kazimierz ^a   Baran, Jarosław ^a   Zembala, Marek ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Microvesicles; Monocytes; Tumour

Indexed keywords

HERMES ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12P40; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR;

ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; CELL CONTACT; CELL INTERACTION; CELL VACUOLE; CYTOKINE PRODUCTION; CYTOSTASIS; CYTOTOXICITY; DRUG ACCUMULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MODULATION; MONOCYTE; PRIORITY JOURNAL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL; TUMOR DERIVED MICROVESICLE;

ANTIGENS, CD14; ANTIGENS, CD44; CELL LINE, TUMOR; CELL MEMBRANE; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; HLA-DR ANTIGENS; HUMANS; MACROPHAGES; MONOCYTES; NEOPLASMS; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; STAT3 TRANSCRIPTION FACTOR;

EID: 35248821267     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2007.07.014     Document Type: Article

References (42)

1. Baj-Krzyworzeka M., Szatanek R., We{ogonek}glarczyk K., Baran J., Urbanowicz B., Brański P., et al. Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes. Cancer Immol Immunother 55 (2006) 808-818
2. Dolo V., Adobati E., Canevari S., Picone M.A., and Vittorelli M.L. Membrane vesicles shed into the extracellular medium by human breast carcinoma cells carry tumor-associated surface antigens. Clin Exp Metastasis 13 (1995) 277-286
3. 1 integrins, and human lymphocyte antigen class I molecules on membrane vesicles shed by 8701-BC breast carcinoma cells. Cancer Res 58 (1998) 4468-4474
4. Shedden K., Xie X.T., Chandaroy P., Chang Y.T., and Rosania G.R. Expulsion of small molecules in vesicles shed by cancer cells: association with gene expression and chemosensitivity profiles. Cancer Res 63 (2003) 4331-4337
5. Andreola G., Rivoltini L., Castelli C., Huber V., Perego P., Deho P., et al. Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles. J Exp Med 195 (2002) 1303-1316
6. Friedl P., Maaser K., Klein C.E., Niggemann B., Krohne G., and Zanker K.S. Migration of highly aggressive MV3 melanoma cells in 3-dimensional collagen lattices results in local matrix reorganization and shedding of α2 and β 1 integrins and CD44. Cancer Res 15 (1997) 2061-2070
7. Ginestra A., Miceli D., Dolo V., Romano F.M., and Vittorelli M.L. Membrane vesicles in ovarian cancer fluids: a new potential marker. Anticancer Res 19 (1999) 3439-3445
8. Poste G., and Nicolson G.L. Arrest and metastasis of blood-borne tumor cells are modified by fusion of plasma membrane vesicles from highly metastatic cells. Proc Natl Acad Sci U.S.A. 77 (1980) 399-403
9. Taverna S., Ghersi G., Ginestra A., Rigogliuso S., Pecorella S., Alaimo G., et al. Shedding of membrane vesicles mediates fibroblast growth factor-2 release from cells. J Biol Chem 19 (2003) 51911-51919
10. Angelucci A., D'Ascenzo S., Festuccia C., Gravina G.L., Bologna M., Dolo V., et al. Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines. Clin Exp Metastasis 18 (2000) 163-170
11. Sidhu S.S., Mengistab A.T., Tauscher A.N., LaVail J., and Basbaum C. The microvesicle as a vehicle for EMMPRIN in tumor-stromal interactions. Oncogene 29 (2004) 956-963
12. Silberberg J.M., Gordon S., and Zucker S. Identification of tissue factor in two human pancreatic cancer cell lines. Cancer Res 1 (1989) 5443-5447
13. Macura-Biegun A., Ruggiero I., Hajto B., and Zembala M. Extracellular matrix proteins modulate cytokine production by monocytes during their interactions with cancer cells. Anticancer Res 23 5A (2003) 4033-4038
14. Pollard J.W. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4 (2004) 71-78
15. Mytar B., Siedlar M., Woloszyn M., Ruggiero I., Pryjma J., and Zembala M. Induction of reactive oxygen intermediates in human monocytes by tumour cells and their role in spontaneous monocytes cytotoxicity. Br J Cancer 79 (1999) 737-743
16. Mytar B., Woloszyn M., Szatanek R., Baj-Krzyworzeka M., Siedlar M., Ruggiero I., et al. Tumor cell-induced deactivation of human monocytes. J Leukoc Biol 74 (2003) 1094-1101
17. Zembala M., Siedlar M., Marcinkiewicz J., and Pryjma J. Human monocytes are stimulated for nitric oxide release in vitro by some tumor cells but not by cytokines and lipopolysaccharide. Eur J Immunol 24 (1994) 435-439
18. Forlow S.B., McEver R.P., and Nollert M.U. Leukocyte-leukocyte interactions mediated by platelet microparticles under flow. Blood 95 (2000) 1317-1323
19. Horstman L.L., Jy W., Jimenez J.J., and Ahn Y.S. Endothelial microparticles as markers of endothelial dysfunction. Front Biosci 9 (2004) 1118-1135
20. Sabatier F., Roux V., Anfosso F., Camoin L., Sampol J., and Dignat-George F. Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity. Blood 99 (2002) 3962-3970
21. Jy W., Minagar A., Jimenez J.J., Sheremata W.A., Mauro L.M., Horstman L.L., et al. Endothelial microparticles (EMP) bind and activate monocytes: elevated EMP-monocyte conjugates in multiple sclerosis. Front Biosci 9 (2004) 3137-3144
22. Baj-Krzyworzeka M., Majka M., Pratico D., Ratajczak J., Vilaire G., Kijowski J., et al. Platelet-derived microparticles stimulate proliferation, survival, adhesion, and chemotaxis of hematopoietic cells. Exp Hematol 30 (2002) 450-459
23. Scholz T., Temmler U., Krause S., Heptinstall S., and Losche W. Transfer of tissue factor from platelets to monocytes: role of platelet-derived microvesicles and CD62P. Thromb Haemost 66 (2002) 1033-1038
24. Barry O.P., Pratico D., Savani R.C., and FitzGerald G.A. Modulation of monocyte-endothelial cell interactions by platelet microparticles. J Clin Invest 102 (1998) 136-144
25. Mesri M., and Altieri D.C. Endothelial cell activation by leukocyte microparticles. J Immunol 161 (1998) 4382-4387
26. Koppler B., Cohen C., Schlondorff D., and Mack M. Differential mechanisms of microparticle transfer to B cells and monocytes: anti-inflammatory properties of microparticles. Eur J Immunol 36 (2006) 648-660
27. Mytar B., Siedlar M., Woloszyn M., Collizzi V., and Zembala M. Cross-talk between human monocytes and cancer cells during reactive oxygen intermediates generation the essential role of essential role of hyaluronan. Int J Cancer 94 (2001) 727-732
28. Rothe G., and Valet G. Flow cytometric analysis of respiratory burst activity in phagocytes with hydroethidine and 2′,7′-dichlorofluorescin. J Leukoc Biol 47 (1990) 440-448
29. Mytar B., Woloszyn M., Macura-Biegun A., Hajto B., Ruggiero I., Piekarska B., et al. Involvement of pattern recognition receptors in the induction of cytokines and reactive oxygen intermediates production by human monocytes/macrophages stimulated with tumour cells. Anticancer Res 24 (2004) 2287-2293
30. Zembala M., Siedlar M., Ruggiero I., Wieckiewicz J., Mytar B., Mattei M., et al. The MHC class II and CD44 molecules are involved in the induction of tumour necrosis factor (TNF) gene expression by human monocytes stimulated with tumour cells. Int J Cancer 56 (1994) 269-274
31. Janicke R., and Mannel D.N. Distinct tumor cell membrane constituents activate human monocytes for tumor necrosis factor synthesis. J Immunol 144 (1990) 1144-1150
32. del Fresno C., Otero K., Gomez-Garcia L., Gonzalez-Leon M.C., Soler-Ranger L., Fuentes-Prior P., et al. Tumor cells deactivate human monocytes by up-regulating IL-1 receptor associated kinase-M expression via CD44 and TLR4. J Immunol 174 (2005) 3032-3040
33. Hiro D., Ito A., Matsuta K., and Mori Y. Hyaluronic acid is an endogenous inducer of interleukin-1 production by human monocytes and rabbit macrophages. Biochem Biophys Res Commun 140 (1986) 715-722
34. Noble P.W., Lake F.R., Henson P.M., and Riches D.W. Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrosis factor-alpha-dependent mechanism in murine macrophages. J Clin Invest 91 (1993) 2368-2377
35. Chappell V.L., Le L.X., LaGrone L., and Mileski W.J. Stat proteins play a role in tumor necrosis factor alpha gene expression. Shock 14 (2000) 400-402
36. Herbeuval J.P., Lelievre E., Lambert C., Dy M., and Genin C. Recruitment of STAT-3 for production of IL-10 by colon carcinoma cells induced by macrophage-derived IL-6. J Immunol 172 (2004) 4630-4636
37. Martin J.H., and Edwards S.W. Changes in mechanisms of monocyte/macrophage-mediated cytotoxicity during culture. Reactive oxygen intermediates are involved in monocyte-mediated cytotoxicity, whereas reactive nitrogen intermediates are employed by macrophages in tumor cell killing. J Immunol 150 (1993) 3478-3486
38. Elgert K.D., Alleva D.G., and Mullins D.W. Tumor-induced immune dysfunction: the macrophage connection. J Leukoc Biol 64 (1998) 275-290
39. Taylor D.D., and Gercel-Taylor C. Tumour-derived exosomes and their role in cancer-associated T-cell signaling defects. Br J Cancer 92 (2005) 305-311
40. Huber V., Fais S., Iero M., Lugini L., Canese P., Squarcina P., et al. Human colorectal cancer cells induce T-cell death through release of proapoptotic microvesicles: role in immune escape. Gastroenterology 128 (2005) 1796-1804
41. Kim J.W., Wieckowski E., Taylor D.D., Reichert T.E., Watkins S., and Whiteside T.L. Fas Ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes. Clin Cancer Res 11 (2005) 1010-1020
42. Bozcuk H., Uslu G., Samur M., Yildiz M., Ozben T., Ozdogan M., et al. Tumour necrosis factor-alpha, interleukin-6, and fasting serum insulin correlate with clinical outcome in metastatic breast cancer patients treated with chemotherapy. Cytokine 27 (2004) 58-65